EUVIMEDEUVIMED entdecken
Crossref

Reply to: Tumor Site Heterogeneity in OrigAMI-4: Biological Implications and Open Questions for OrigAMI-5

Barbara Burtness iD, Kiichiro Toyoizumi iD, Emrullah Yilmaz iD, Kevin J Harrington iD

Journal of Clinical Oncology · 17.11.2026

DOI: 10.1200/jco-26-02504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, online erschienen am 17.11.2026. Verfasst von Barbara Burtness und 3 weiteren Autor:innen. Beteiligte Einrichtung: Barbara Burtness, MD, Department of Internal Medicine and Yale Cancer Center, Yale School of Medicine, New Haven, CT; Kiichiro Toyoizumi, PhD, Johnso…. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Barbara Burtness, MD, Department of Internal Medicine and Yale Cancer Center, Yale School of Medicine, New Haven, CT; Kiichiro Toyoizumi, PhD, Johnson & Johnson, Tokyo, Japan; Emrullah Yilmaz, MD, PhD, Johnson & Johnson…

ORCID-Profile: Barbara Burtness, Kiichiro Toyoizumi, Emrullah Yilmaz, Kevin J Harrington

Zitieren

APA

Burtness, B., Toyoizumi, K., Yilmaz, E., & Harrington, K. J. (2026). Reply to: Tumor Site Heterogeneity in OrigAMI-4: Biological Implications and Open Questions for OrigAMI-5. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-02504

Vancouver

Burtness B, Toyoizumi K, Yilmaz E, Harrington KJ. Reply to: Tumor Site Heterogeneity in OrigAMI-4: Biological Implications and Open Questions for OrigAMI-5. Journal of Clinical Oncology. 2026. doi:10.1200/jco-26-02504

BibTeX
@article{Burtness2026,
  author = {Burtness, Barbara and Toyoizumi, Kiichiro and Yilmaz, Emrullah and Harrington, Kevin J},
  title = {Reply to: Tumor Site Heterogeneity in OrigAMI-4: Biological Implications and Open Questions for OrigAMI-5},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  doi = {10.1200/jco-26-02504}
}
Kostenlos starten →